GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- C5331 O-Phospho-D-SerineSummary: weak agonist of the metabotropic glutamate receptor mGluR4
- C5367 6-OAUSummary: synthetic agonist for GPR84
- C5386 N-AcetylserotoninSummary: an agonist at the melatonin receptors MT1, MT2, and MT3
- C5324 U-44069Summary: TP receptor agonist
- C5718 ML-031Summary: agonist of S1P2
- C5611 VU0483605Summary: elective positive allosteric modulator (PAM) of mGluR1
- C5580 RaceanisodamineSummary: weak antagonist of α1-adrenoceptors
- C5509 S-1 MethanandamideSummary: CB1 receptor ligand
- C5513 S-2 MethanandamideSummary: potent CB1 receptor agonist
- C5416 REV 5901Summary: antagonist of cysteinyl-leukotriene receptors